Exelixis
EXEL
#1760
Rank
ยฃ8.83 B
Marketcap
ยฃ32.80
Share price
-0.25%
Change (1 day)
13.42%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company